TLR9 signaling in fibroblastic reticular cells regulates peritoneal immunity.

Fibroblastic reticular cells (FRCs), a subpopulation of stromal cells in lymphoid organs and fat-associated lymphoid clusters (FALCs) in adipose tissue, play immune-regulatory roles in the host response to infection and may be useful as a form of cell therapy in sepsis. Here, we found an unexpected major role of TLR9 in controlling peritoneal immune cell recruitment and FALC formation at baseline and after sepsis induced by cecal ligation and puncture (CLP). TLR9 regulated peritoneal immunity via suppression of chemokine production by FRCs. Adoptive transfer of TLR9-deficient FRCs more effectively decreased mortality, bacterial load, and systemic inflammation after CLP than WT FRCs. Importantly, we found that activation of TLR9 signaling suppressed chemokine production by human adipose tissue-derived FRCs. Together, our results indicate that TLR9 plays critical roles in regulating peritoneal immunity via suppression of chemokine production by FRCs. These data form a knowledge basis upon which to design new therapeutic strategies to improve the therapeutic efficacy of FRC-based treatments for sepsis and immune dysregulation diseases.

[1]  Katherine R. Balka,et al.  Understanding early TLR signaling through the Myddosome , 2018, Journal of leukocyte biology.

[2]  N. Kissoon,et al.  The global burden of sepsis: barriers and potential solutions , 2018, Critical Care.

[3]  M. Robinson,et al.  Fibroblastic reticular cells initiate immune responses in visceral adipose tissues and secure peritoneal immunity , 2018, Science Immunology.

[4]  P. Tak,et al.  Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis , 2018, Arthritis Research & Therapy.

[5]  J. Laffey,et al.  Stem Cell–based Therapies for Sepsis , 2017, Anesthesiology.

[6]  L. Reppel,et al.  Mesenchymal Stromal/Stem Cells: A New Treatment For Sepsis And Septic Shock? , 2017 .

[7]  E. Jiménez,et al.  Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools. , 2017, Cytotherapy.

[8]  N. Ohashi,et al.  Role of Mitochondrial DNA in Septic AKI via Toll-Like Receptor 9. , 2016, Journal of the American Society of Nephrology : JASN.

[9]  T. Billiar,et al.  Toll-like Receptor 4 Signaling on Dendritic Cells Suppresses Polymorphonuclear Leukocyte CXCR2 Expression and Trafficking via Interleukin 10 During Intra-abdominal Sepsis. , 2016, The Journal of infectious diseases.

[10]  J. Coligan,et al.  Emerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune Homeostasis , 2016, Front. Immunol..

[11]  R. Coffman,et al.  Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. , 2016, The Journal of clinical investigation.

[12]  G. Kollias,et al.  Inflammation-induced formation of fat-associated lymphoid clusters , 2015, Nature Immunology.

[13]  D. Yin,et al.  Inhibition of Toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response. , 2015, Cellular immunology.

[14]  S. Acton,et al.  Lymph node fibroblastic reticular cells in health and disease , 2015, Nature Reviews Immunology.

[15]  S. Turley,et al.  Fibroblastic Reticular Cells: Organization and Regulation of the T Lymphocyte Life Cycle , 2015, The Journal of Immunology.

[16]  T. Billiar,et al.  Shedding of the tumor necrosis factor (TNF) receptor from the surface of hepatocytes during sepsis limits inflammation through cGMP signaling , 2015, Science Signaling.

[17]  G. Barton,et al.  MyD88: a central player in innate immune signaling , 2014, F1000prime reports.

[18]  D. Mooney,et al.  The CLEC-2–podoplanin axis controls fibroblastic reticular cell contractility and lymph node microarchitecture , 2014, Nature Immunology.

[19]  Robert P. Jenkins,et al.  Dendritic Cells Control Fibroblastic Reticular Network Tension and Lymph Node Expansion , 2014, Nature.

[20]  Burkhard Ludewig,et al.  B cell homeostasis and follicle confines are governed by fibroblastic reticular cells , 2014, Nature Immunology.

[21]  T. Heng,et al.  Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis , 2014, Science Translational Medicine.

[22]  T. Renno,et al.  Dual function of MyD88 in inflammation and oncogenesis: implications for therapeutic intervention , 2014, Current opinion in oncology.

[23]  G. Trinchieri,et al.  MyD88 and its divergent toll in carcinogenesis. , 2013, Trends in immunology.

[24]  S. Zakynthinos,et al.  CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[25]  Simon C Watkins,et al.  Lipopolysaccharide Clearance, Bacterial Clearance, and Systemic Inflammatory Responses Are Regulated by Cell Type–Specific Functions of TLR4 during Sepsis , 2013, The Journal of Immunology.

[26]  T. Ohnishi,et al.  LPS‐induced chemokine expression in both MyD88‐dependent and ‐independent manners is regulated by Cot/Tpl2‐ERK axis in macrophages , 2012, FEBS letters.

[27]  D. Mooney,et al.  Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks , 2012, Nature Immunology.

[28]  H. Frankel,et al.  Treatment of sepsis in the surgical intensive care unit. , 2011, The Israel Medical Association journal : IMAJ.

[29]  R. Daniels.  Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective). , 2011, The Journal of antimicrobial chemotherapy.

[30]  S. Turley,et al.  Br Ief Definitive Repor T , 2022 .

[31]  J. Shupe,et al.  TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus , 2010, The Journal of Immunology.

[32]  G. Plitas,et al.  Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis , 2008, The Journal of experimental medicine.

[33]  J. Shupe,et al.  Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.

[34]  Carl Nathan,et al.  Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.

[35]  Hua Tang,et al.  Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. , 2005, Blood.

[36]  K. Haas,et al.  B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. , 2005, Immunity.

[37]  J. Hamilton,et al.  Stimulus-Dependent Requirement for Granulocyte-Macrophage Colony-Stimulating Factor in Inflammation1 , 2004, The Journal of Immunology.

[38]  R. Flavell,et al.  Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Figdor,et al.  BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo , 2001, European journal of immunology.

[40]  Jianzhu Chen,et al.  B-1 and B-2 Cell–Derived Immunoglobulin M Antibodies Are Nonredundant Components of the Protective Response to Influenza Virus Infection , 2000, The Journal of experimental medicine.

[41]  R. Zinkernagel,et al.  Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.

[42]  Jason G. Cyster,et al.  A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.

[43]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[44]  J. Vincent.  Acute kidney injury, acute lung injury and septic shock: how does mortality compare? , 2011, Contributions to nephrology.